Clinical Trials Logo

Filter by:
NCT ID: NCT04548180 Completed - Clinical trials for Traumatic Brain Injury

Genome-Wide Assocation Study in Patients With Brain Injury Associated Fatigue and Altered Cognition (BIAFAC)

Start date: June 21, 2021
Phase:
Study type: Observational

The aim of this study is elucidate genetic susceptibility of patients with traumatic brain injury (TBI) and symptoms of Brain Injury Associated Fatigue and Altered Cognition (BIAFAC) using genome-wide association study (GWAS).

NCT ID: NCT04548154 Completed - Multiple Sclerosis Clinical Trials

Proximal Resistance Training for People With Multiple Sclerosis

PT-MS
Start date: October 12, 2020
Phase: N/A
Study type: Interventional

The objective of this study is to pilot a 10-week resistance and functional movement intervention targeting proximal muscles in 40 people with MS. The investigators will assess implementation feasibility (recruitment, fidelity, retention, satisfaction), collect pilot data for key walking function outcomes, and examine movement-pattern and activity behavior mechanisms. Walking function will be measured by walking capacity (6-Minute Walk Test - 6MWT) and PA quantity (average steps/ day over 10 days). Movement-pattern mechanisms will be measured using 3D motion capture analysis (pelvis and trunk kinematics). Activity behavior mechanisms will be measured by patient-reported outcome questionnaires (perception of walking ability, self-efficacy, and readiness to change).

NCT ID: NCT04548128 Completed - Clinical trials for Advanced Refractory Left Ventricular Heart Failure

Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS

SWIFT
Start date: November 17, 2020
Phase:
Study type: Observational

This is a prospective, post-market, multi-center, non-blinded, single arm study of the HeartMate 3 Left Ventricular Assist System (LVAS). The objective of this study is to evaluate the implantation of the HM3 utilizing techniques other than full median sternotomy (e.g. thoracotomy) and impact on post-implant length of stay.

NCT ID: NCT04547998 Completed - Vitiligo Clinical Trials

Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

Start date: September 10, 2020
Phase: N/A
Study type: Interventional

This is a prospective blinded within-subject randomized study to evaluate the application of Spray-On Skin™ Cells, prepared using the RECELL® Device for safe and effective repigmentation of ablated stable vitiligo lesions.

NCT ID: NCT04547920 Completed - Overactive Bladder Clinical Trials

FREEOAB Study for Overactive Bladder

Start date: January 11, 2021
Phase: N/A
Study type: Interventional

This is a prospective, multicenter study that was conducted to evaluate the safety and efficacy of a novel, closed-loop, continuous-sensing wearable neuromodulation system for Overactive Bladder symptom control. The end points were refined based on FDA feedback and the data was analyzed post-hoc based on these endpoints, combining the group into a single study arm.

NCT ID: NCT04547881 Completed - Clinical trials for Esophageal Neoplasms

Gravity Assisted Technique for Esophageal Endoscopic Submucosal Dissection (ESD)

Start date: December 12, 2016
Phase:
Study type: Observational [Patient Registry]

This is a prospective data recording study, all patients will receive standard medical care and no experimental interventions will be performed. All patients scheduled to undergo esophageal ESD from December 2018 to December 2021 as medically indicated will be considered for the study, Patients in whom esophageal ESD is considered as part of their standard medical care will be offered to participate in this study. The principle investigator who performing the procedure will also discuss the study with the subjects and ask them to sign a consent. If the patient agrees to participate, he/she will be given the informed consent form and allowed enough time to read it. Then if the patient agrees, he/she will sign the consent form. Data will be prospectively recorded according to the data collection form.

NCT ID: NCT04547803 Completed - Hospital Discharge Clinical Trials

Post-discharge Early Assessment With a Video-visit

Start date: August 10, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if a video visit with an advanced practice provider (Nurse Practitioner or Physician Assistant) within 7 days of discharge from Hospital Internal Medicine services will increase patient compliance with medication, self-management and home supports after hospital discharge.

NCT ID: NCT04547790 Completed - Type2 Diabetes Clinical Trials

A Study to Assess the Effect of Psyllium vs. Wheat Dextrin on Glycemic Control and Inflammatory Markets in Diabetes Mellitus 2

Start date: December 23, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine which of Psyllium and Wheat Dextrin is more effective in lowering fasting blood sugar and hemoglobin A1c, and to evaluate the effects they have on laboratory values.

NCT ID: NCT04547361 Completed - Healthy Volunteers Clinical Trials

A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants

Start date: September 14, 2020
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate the safety, tolerability, and pharmacokinetic (PK) of E2511 following single ascending oral doses in healthy adult and elderly participants.

NCT ID: NCT04547283 Completed - Covid19 Clinical Trials

Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19

Start date: June 14, 2020
Phase: N/A
Study type: Interventional

This study aims to determine if a strategy of recommending prone (on stomach) positioning of patients positive or suspected positive for coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, but not mechanically ventilated, Is feasible in the inpatient setting. This study will be performed as a pragmatic pilot clinical trial to gain information relevant to the future conduct of a larger trial.